Abstract:Purpose: The primary aim of this study was to investigate, using an experimental rat model of osteoarthritis(OA), the effect of a selective p38 mitogen activated protein kinase inhibitor,SB203580, on the development of structural changes.Additional aims were to assess the effects of the inhibitor on levels of matrixmetalloproteinase 3 (MMP-3) and MMP-13(collagenase 3) in OA cartilage and to explore the relation between the MMP-3,13 expression and the severity of OA. Methods: OA was induced in 40 SD rats by anterior cruciate ligament transection (ACLT).After surgical, rats with OA were randomly divided into A_D groups: Rats of group A received 0.1 ml intra-articular injection of SB203580 at high concentration of 100um/L. Each treatment started immediately after surgery, once a week;those in group B were treated under the same condition using SB203580 with low concentration of 10um/L and those in group C received 0.1ml of intra-articular 0.9% Sodium Chloride injection,animals of group D were not injected as controls after ACLT. The animals were killed 8 weeks after surgery. Macroscopicand histologic studies were performed on the cartilage. The levels of MMP-3,13 in OA cartilage chondrocytes were evaluated by immunohistochemistry and western-blotting. Results: All ACLT knees demonstrated osteoarthritic changes. Cartilage degradation in the control group was significantly more severe than that in the experimental group both on the macroscopic grading scale and on Mankin’s grading scale(P <0.05). Immunohistochemical study showed that in the experimental group MMP-3,13 was predominantly expressed in the superficial and upper intermediate layers of cartilage, and the amount of MMP-3,13 in the experimental group was also lower than that in control group(P <0.05). In western-blotting the amount of MMP3,13 was reduced by the treatment of the inhibitor. The protein levels of MMP-3 and MMP-13 in cartilage of inhibitor injection groups were significantly lower than those of Sodium Chloride group and untreated group. There was no significant difference in MMP-3 and MMP-13 expression between the different concentration inhibitor injection groups. No significant difference in MMP-3 and MMP-13 expression in cartilage was found between Sodium Chloride group and control group. Conclusions: This study demonstrates that, in vivo,SB203580, a selective inhibitor of p38MAPK, can partially decrease the development of some of the structural changes in the early phases of experimental OA and significantly reduces the severity of cartilage degradation. This effect was associated with a reduction in the level of MMP-3,13 in OA cartilage, which probably explains the action of the drug and thus may be a potential drug for the treatment of OA.

Inhibitory effects of RNA interference on the expression of MMP13 in the ehondrocyte of rabbit with osteoarthritis

P93 Angiogenesis in Human and Guinea Pig Osteoarthritis

Effect of the Interaction Between MiR-200b-3p and DNMT3A on Cartilage Cells of Osteoarthritis Patients.

Effect of Dehydroepiandrosterone on Mrna Expression of MMP-3, TIMP-1 and IL-1β in the Cartilage and Synovium of Rabbits with Osteoarthritis

piRNA mmu_piR_037459 suppression alleviated the degeneration of chondrocyte and cartilage

Circ_0136474 and MMP-13 Suppressed Cell Proliferation by Competitive Binding to Mir-127-5p in Osteoarthritis

Therapeutic Potential of POU3F3, a Novel Long Non-coding RNA, Alleviates the Pathogenesis of Osteoarthritis by Regulating the miR-29a-3p/FOXO3 Axis

Anti-arthritic effects of chlorogenic acid in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model.

Effect of Lentivirus-Mediated Upa Silencing on the Proliferation and Apoptosis of Chondrocytes and the Expression of MMPs

Expression of Matrix Metalloproteinase-1, Matrix Metalloproteinase-3, Interleukin-1Β and Chondrocyte Apoptosis in Rabbit Osteoarthritis

Effect of Expression of Upa and MMP-3 in Rabbit Chondrocyte Mediated by Upa-Sirna Lentiviral Vector

Intra-articular Injection of Mirna-1 Agomir, a Novel Chemically Modified Mirna Agonists Alleviates Osteoarthritis (OA) Progression by Downregulating Indian Hedgehog in Rats

Effects of RNA Interference Against Aggrecanase 1 Gene on Extracellular Matrix Metabolism of Cultured Chondrocytes in Vitro

Intra-articular Injection of Microrna-140 (Mirna-140) Alleviates Osteoarthritis (OA) Progression by Modulating Extracellular Matrix (ECM) Homeostasis in Rats.

Microrna-193b-3p Regulates Matrix Metalloproteinase 19 Expression In Interleukin-1 Beta-Induced Human Chondrocytes

Effect of 1,25-(OH)2D3 on Proliferation of Fibroblast-Like Synoviocytes and Expressions of Pro-Inflammatory Cytokines Through Regulating MicroRNA-22 in a Rat Model of Rheumatoid Arthritis.

RNAi Silencing of WISP-1 Gene in the Treatment of Osteoarthritis

P173 THE EFFECTS OF INTRA-ARTICULAR INJECTION OF P38 MAPK INHIBITOR ON MATRIX METALLOPROTEINASE IN CARTILAGE OF EXPERIMENTAL OSTEOARTHRITIS MODEL

An in vitro study on rabbit osteoarthritis gene therapy with GGCX gene

The miRNA-206 mediated the differentiation of bone mesenchymal stem cells into chondrocytes and its effect in osteoarthritis models

Up-regulated expression of miRNA-543 in protecting chondrocytes in rat model of osteoarthritis